Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutaro Mukai

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|July 23, 2016
Long-term impact of therapeutic drug monitoring on the risk of hypoglycemia in HOCM patients on cibenzoline therapy
Yutaro Mukai, Kyoichi Wada, Mai Fujimoto, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 2, 2022
Pharmacokinetics and pharmacodynamics of amiodarone in patients with hypertriglyceridemia: Two case reportsTakaya Uno, Kota Sakakura, Yutaro Mukai, et al.
Cureus|September 22, 2025
Association Between Kounis Syndrome and Allergy-Associated Coronary Events: A Disproportionality Analysis Using the Japanese Adverse Drug Event Report DatabaseIchiro Nakakura, Yutaro Mukai, Atsuki Hosoda, et al.
Journal of Pharmaceutical Health Care and Sciences|February 4, 2026
Comparative clinical features of antibiotic-associated Kounis syndrome and non-Kounis allergic coronary events: a disproportionality analysis using U.S. Food and Drug Administration Adverse Event Reporting SystemIchiro Nakakura, Yutaro Mukai, Atsuki Hosoda, et al.
Journal of Arrhythmia|October 13, 2017
The influence of residual apixaban on bleeding complications during and after catheter ablation of atrial fibrillationYutaro Mukai, Kyoichi Wada, Koji Miyamoto, et al.
European Journal of Clinical Pharmacology|May 22, 2018
Effects of vitamin K epoxide reductase complex 1 gene polymorphisms on warfarin control in Japanese patients with left ventricular assist devices (LVAD)Kazuki Nakagita, Kyoichi Wada, Yutaro Mukai, et al.
Pharmacology Research & Perspectives|April 17, 2026
Intravenous Tolvaptan Sodium Phosphate Can Fail to Improve Fluid Overload Due to Heart Failure in Patients With Chronic Kidney Disease: A Case ReportTakaya Uno, Ichiro Nakakura, Akari Ikeda, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 7, 2020
Relationship between serum bepridil concentration and corrected QT intervalKazuki Matsui, Yutaro Mukai, Kota Sakakura, et al.
Journal of Pharmacological Sciences|September 8, 2019
Genetic deletion of Ca<sub>v</sub>3.2 T-type calcium channels abolishes H<sub>2</sub>S-dependent somatic and visceral pain signaling in C57BL/6 miceKazuki Matsui, Maho Tsubota, Saaya Fukushi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Clinical Pharmacology and Therapeutics|July 23, 2016
Long-term impact of therapeutic drug monitoring on the risk of hypoglycemia in HOCM patients on cibenzoline therapy
Yutaro Mukai, Kyoichi Wada, Mai Fujimoto, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 2, 2022
Pharmacokinetics and pharmacodynamics of amiodarone in patients with hypertriglyceridemia: Two case reportsTakaya Uno, Kota Sakakura, Yutaro Mukai, et al.
Cureus|September 22, 2025
Association Between Kounis Syndrome and Allergy-Associated Coronary Events: A Disproportionality Analysis Using the Japanese Adverse Drug Event Report DatabaseIchiro Nakakura, Yutaro Mukai, Atsuki Hosoda, et al.
Journal of Pharmaceutical Health Care and Sciences|February 4, 2026
Comparative clinical features of antibiotic-associated Kounis syndrome and non-Kounis allergic coronary events: a disproportionality analysis using U.S. Food and Drug Administration Adverse Event Reporting SystemIchiro Nakakura, Yutaro Mukai, Atsuki Hosoda, et al.
Journal of Arrhythmia|October 13, 2017
The influence of residual apixaban on bleeding complications during and after catheter ablation of atrial fibrillationYutaro Mukai, Kyoichi Wada, Koji Miyamoto, et al.
European Journal of Clinical Pharmacology|May 22, 2018
Effects of vitamin K epoxide reductase complex 1 gene polymorphisms on warfarin control in Japanese patients with left ventricular assist devices (LVAD)Kazuki Nakagita, Kyoichi Wada, Yutaro Mukai, et al.
Pharmacology Research & Perspectives|April 17, 2026
Intravenous Tolvaptan Sodium Phosphate Can Fail to Improve Fluid Overload Due to Heart Failure in Patients With Chronic Kidney Disease: A Case ReportTakaya Uno, Ichiro Nakakura, Akari Ikeda, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 7, 2020
Relationship between serum bepridil concentration and corrected QT intervalKazuki Matsui, Yutaro Mukai, Kota Sakakura, et al.
Journal of Pharmacological Sciences|September 8, 2019
Genetic deletion of Ca<sub>v</sub>3.2 T-type calcium channels abolishes H<sub>2</sub>S-dependent somatic and visceral pain signaling in C57BL/6 miceKazuki Matsui, Maho Tsubota, Saaya Fukushi, et al.
Pageof 1